Preferred Label : VEGFR2-targeted Contrast Agent BR55;
NCIt definition : A lipopeptide-based, vascular endothelial growth factor receptor 2 (VEGRF2) -targeted
contrast agent with the property of molecular imaging of angiogenesis. BR55 is prepared
by incorporation of a biospecific heterodimer peptide into the perfluorobutane-containing
lipid-shelled microbubble membrane; the peptide specifically binds to VEGFR2 expressed
on tumoral vascular endothelium allowing ultrasound imaging of the sites of active
angiogenesis.;
Molecule name : BR55;
NCI Metathesaurus CUI : CL426694;
Origin ID : C95204;
UMLS CUI : C2986991;
Semantic type(s)
- concept_is_in_subset
